Published December 2020 | Version v1
Journal article

Chest CT practice and protocols for COVID-19 from radiation dose management perspective

  • 1. Harvard Medical School, Boston, MA (United States)
  • 2. Department of Radiology, Webster Center for Quality and Safety, Massachusetts General Hospital, Boston, MA (United States)
  • 3. International Atomic Energy Agency, Vienna (Austria)

Description

The global pandemic of coronavirus disease 2019 (COVID-19) has upended the world with over 6.6 million infections and over 391,000 deaths worldwide. Reverse-transcription polymerase chain reaction (RT-PCR) assay is the preferred method of diagnosis of COVID-19 infection. Yet, chest CT is often used in patients with known or suspected COVID-19 due to regional preferences, lack of availability of PCR assays, and false-negative PCR assays, as well as for monitoring of disease progression, complications, and treatment response. The International Atomic Energy Agency (IAEA) organized a webinar to discuss CT practice and protocol optimization from a radiation protection perspective on April 9, 2020, and surveyed participants from five continents. We review important aspects of CT in COVID-19 infection from the justification of its use to specific scan protocols for optimizing radiation dose and diagnostic information.

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-020-07034-x

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology
Journal Volume
30
Journal Issue
12
Journal Page Range
p. 6554-6560
ISSN
0938-7994
CODEN
EURAE3